Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,135
Total Claims
$844K
Drug Cost
611
Beneficiaries
$1,382
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+55%
Opioid rate vs peers
4.0% vs 2.6% avg
+29%
Cost per patient vs peers
$1,382 vs $1,068 avg
+47%
Brand preference vs peers
13.3% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
4.0%
Opioid Rate
404
Opioid Claims
$8,106
Opioid Cost
11.1%
Long-Acting Rate
Brand vs Generic
Brand: 1,330 claims · $626K
Generic: 8,695 claims · $212K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 134 | $97K |
| Empagliflozin | 65 | $51K |
| Semaglutide | 20 | $48K |
| Insulin Glargine,hum.Rec.Anlog | 109 | $43K |
| Liraglutide | 20 | $39K |
| Rivaroxaban | 78 | $36K |
| Sitagliptin Phosphate | 12 | $20K |
| Dapagliflozin Propanediol | 52 | $20K |
| Fluticasone/Umeclidin/Vilanter | 25 | $19K |
| Liraglutide | 14 | $17K |
| Insulin Aspart | 21 | $16K |
| Semaglutide | 13 | $15K |
| Potassium Chloride | 164 | $14K |
| Budesonide/Formoterol Fumarate | 21 | $12K |
| Lumateperone Tosylate | 13 | $10K |
Prescribing Profile
Patient Profile
74
Avg Age
72%
Female
1.50
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About